![]()
|
|
||||||||
J. Biol. Chem., Vol. 265, Issue 36, 22243-22254, 12, 1990
M Faber and L Sealy
We have characterized enhancer factor I (EFI), a trans-acting factor
present in avian nuclear extracts which binds to the Rous sarcoma virus
long terminal repeat enhancer and promoter. Through deletion and point
mutagenesis, we show that EFI is a member of the CCAAT family of
transcription factors. Although the CCAAT motif is essential for
protein-DNA recognition, EFI shows surprising latitude in the nucleotide
sequences flanking the CCAAT motif to which it will bind with high
affinity. EFI will cross-bind to the binding sites of a number of
previously described CCAAT factors, including CBF, NF-Y, CP2, CP1,
CTF/NF-1, and c/EBP, with a range of affinities that is at most 10- fold
lower than the high affinity binding site for EFI in the Rous sarcoma virus
long terminal repeat. We present evidence, however, that EFI is probably
identical or very closely related to CBF and NF-Y. This is based on the
fact that EFI in avian nuclear extracts binds with equal or 2-fold greater
affinity to the binding sites of NF-Y and CBF, despite less than 50%
homology (outside the CCAAT motif) between the EFI, NF-Y, and CBF
recognition sequences. Moreover, radiolabeled EFI, NF-Y, or CBF DNAs give
rise to identical gel retardation patterns in extracts from a variety of
different cell types. EFI, CBF, and NF-Y appear to fractionate identically
upon ion exchange chromatography, separating into two heterologous
components (A and B) which must be recombined to recover substantial DNA
binding activity. Molecular weight estimates for the two heterologous
components of EFI, CBF, and a Y-box binding protein (Celada, A., and Maki,
R.A. (1989) Mol. Cell. Biol. 9, 3097-3100) are very similar. EFI DNA
binding activity has recently been shown to be induced by serum and the
oncogene v-src (Dutta, A., Stoeckle, M.Y., and Hanafusa, H. (1990) Genes
& Dev. 4, 243- 254). The close relationship or identity between EFI,
CBF, and NF-Y, thus has important implications regarding the mechanisms by
which serum or the oncogene v-src may affect changes in gene expression.
Rous sarcoma virus enhancer factor I is a ubiquitous CCAAT transcription factor highly related to CBF and NF-Y
Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. Shao and K. Sperber Impaired Regulation of HLA-DR Expression in Human Immunodeficiency Virus-Infected Monocytes Clin. Vaccine Immunol., July 1, 2002; 9(4): 739 - 746. [Full Text] [PDF] |
||||
![]() |
P. S. Holm, S. Bergmann, K. Jurchott, H. Lage, K. Brand, A. Ladhoff, K. Mantwill, D. T. Curiel, M. Dobbelstein, M. Dietel, et al. YB-1 Relocates to the Nucleus in Adenovirus-infected Cells and Facilitates Viral Replication by Inducing E2 Gene Expression through the E2 Late Promoter J. Biol. Chem., March 15, 2002; 277(12): 10427 - 10434. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rakoff-Nahoum, H. Chen, T. Kraus, I. George, E. Oei, M. Tyorkin, E. Salik, P. Beuria, and K. Sperber Regulation of Class II Expression in Monocytic Cells after HIV-1 Infection J. Immunol., August 15, 2001; 167(4): 2331 - 2342. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhao, M. A. Cissell, E. Henderson, R. Colbran, and R. Stein The RIPE3b1 Activator of the Insulin Gene Is Composed of a Protein(s) of Approximately 43 kDa, Whose DNA Binding Activity Is Inhibited by Protein Phosphatase Treatment J. Biol. Chem., March 31, 2000; 275(14): 10532 - 10537. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Mobley and L. Sealy Role of the Transcription Start Site Core Region and Transcription Factor YY1 in Rous Sarcoma Virus Long Terminal Repeat Promoter Activity J. Virol., August 1, 1998; 72(8): 6592 - 6601. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nambiar, S. K. Swamynathan, J. C. Kandala, and R. V. Guntaka Characterization of the DNA-Binding Domain of the Avian Y-Box Protein, chkYB-2, and Mutational Analysis of Its Single-Strand Binding Motif in the Rous Sarcoma Virus Enhancer J. Virol., February 1, 1998; 72(2): 900 - 909. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. B. de Medeiros, G. Krey, A. K. Hihi, and W. Wahli Functional Interactions between the Estrogen Receptor and the Transcription Activator Sp1 Regulate the Estrogen-dependent Transcriptional Activity of the Vitellogenin A1 io Promoter J. Biol. Chem., July 18, 1997; 272(29): 18250 - 18260. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Tezuka, D. T. Denhardt, G. A. Rodan, and S.-i. Harada Stimulation of Mouse Osteopontin Promoter by v-Src Is Mediated by a CCAAT Box-binding Factor J. Biol. Chem., September 13, 1996; 271(37): 22713 - 22717. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Sapru, J. P. Gao, W. Walke, M. Burmeister, and D. Goldman Cloning and Characterization of a Novel Transcriptional Repressor of the Nicotinic Acetylcholine Receptor [IMAGE]-Subunit Gene J. Biol. Chem., March 22, 1996; 271(12): 7203 - 7211. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Wright, T. L. Moore, B. J. Vilen, A. M. Brown, and , J. P.-Y. Ting Major Histocompatibility Complex Class II-associated Invariant Chain Gene Expression Is Up-regulated by Cooperative Interactions of Sp1 and NF-Y J. Biol. Chem., September 8, 1995; 270(36): 20978 - 20986. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. MacDonald, Y. Itoh-Lindstrom, and J. P.-Y. Ting The Transcriptional Regulatory Protein, YB-1, Promotes Single-stranded Regions in the DRA Promoter J. Biol. Chem., February 24, 1995; 270(8): 3527 - 3533. [Abstract] [Full Text] [PDF] |
||||
![]() |
S R Hann, M Dixit, R C Sears, and L Sealy The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site. Genes & Dev., October 15, 1994; 8(20): 2441 - 2452. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |